P2RY12 and acute coronary syndrome: Pre-treatment with anti-platelet agents, the co-administration of aspirin and a second agent such as P2Y12 or glycoprotein IIb/IIIa inhibitors prior to coronary angiography in patients with acute coronary syndromes without ST elevation, remains a complex and controversial topic in the current era [1,2].